Phenylmorphans and analogues: Opioid receptor subtype selectivity and effect of conformation on activity Journal Article
| Authors: | Froimowitz, M.; Pick, C. G.; Pasternak, G. W. |
| Article Title: | Phenylmorphans and analogues: Opioid receptor subtype selectivity and effect of conformation on activity |
| Abstract: | The morphine-like (+)-phenylmorphan, the atypical (-)-enantiomer, and some analogues have been tested in receptor binding assays selective for opioid μ1, μ2,δ, k1, and k3 receptors. The affinities of all of the compounds except one, including the atypical (-)-phenylmorphan, were greatest for μ1 and μ2 receptors. The only exception was the (+)-9α-methyl analogue which had slightly greater affinity for the k1 receptor. The selective receptor binding assays provide evidence that opioids in which the phenyl ring is constrained to be equatorial on the piperidine ring can have considerable affinity for μ receptors. In addition, dose-response curves were determined for (+)-and (-)-phenylmorphan using the mouse tail-flick assay with the (+)-enantiomer found to be about 7 times more potent. Pretreatment with the selective opioid antagonists β-FNA (μ1 and μ2, naloxonazine (μ1), nor-BNI (k1), and naltrindole (δ) suggests that the antinociceptive activity of both enantiomers is mediated through μ receptors. The pretreatment with naloxonazine, which attentuated the antinociceptive effect, shows that both (+)-and (-)-phenylmorphan are μ1 agonists while intrathecal administration shows that both are μ2 agonists. Conformational energy calculations on the compounds were also performed using the MM2-87 program. Consistent with previous conformational results for the phenylmorphans (J. Med. Chem. 1984, 27, 1234-1237), the most potent antinociceptive compounds preferred a particular orientation of the phenyl ring. © 1992, American Chemical Society. All rights reserved. |
| Keywords: | controlled study; unclassified drug; drug activity; dose response; nonhuman; binding affinity; mouse; animal; mice; animal tissue; structure activity relation; structure-activity relationship; drug receptor binding; substrate specificity; morphine; analgesics; mu opiate receptor; receptors, opioid, mu; molecular conformation; opiate receptor; enkephalin[2,5 dextro penicillamine]; opiate antagonist; receptors, opioid, delta; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide methanesulfonate; drug conformation; antinociception; enantiomer; subcutaneous drug administration; opiate agonist; receptors, opioid; male; priority journal; article; receptors, opioid, kappa; support, u.s. gov't, p.h.s.; intrathecal drug administration; phenylmorphan; phenylmorphan derivative; morphinans |
| Journal Title: | Journal of Medicinal Chemistry |
| Volume: | 35 |
| Issue: | 9 |
| ISSN: | 0022-2623 |
| Publisher: | American Chemical Society |
| Date Published: | 1992-05-01 |
| Start Page: | 1521 |
| End Page: | 1525 |
| Language: | English |
| DOI: | 10.1021/jm00087a004 |
| PUBMED: | 1315868 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work